Advertisement

Topics

FDA fast-tracks SpringWorks' desmoid tumor candidate

04:54 EST 9 Nov 2018 | SmartBrief

SpringWorks Therapeutics' nirogacestat, being developed to treat adult patients with desmoid tumors that are progressive, unr -More

Original Article: FDA fast-tracks SpringWorks' desmoid tumor candidate

NEXT ARTICLE

More From BioPortfolio on "FDA fast-tracks SpringWorks' desmoid tumor candidate"

Advertisement
Quick Search
Advertisement
Advertisement